Evaluating the Minimal Clinically Important Difference of the King’s Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P. Baughman, Surinder S. Birring, Elyse E. Lower et al.|Annals of the American Thoracic Society|2020Cited by 33
The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)Marc A. Judson, Robert P. Baughman, Recai Yucel et al.|Respiratory Medicine|2022Cited by 4
Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis.Rebecca Klein, Robert P. Baughman, Marc A. Judson et al.|PubMed|2023Cited by 3
Evaluating the Minimal Clinically Important Difference of the King'S Sarcoidosis Questionnaire (KSQ) in a Multi-Center, Prospective TrialR.P. Baughman, SS Birring, Marc A. Judson et al.|Unknown|2020Cited by 1